Publication Cover
Global Public Health
An International Journal for Research, Policy and Practice
Volume 18, 2023 - Issue 1
1,428
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Evidence on factors influencing HPV vaccine implementation in South Asia: A scoping review

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2288269 | Received 08 Jun 2023, Accepted 08 Nov 2023, Published online: 08 Dec 2023

References

  • Ahmed, D., VanderEnde, K., Harvey, P., Bhatnagar, P., Kaur, N., Roy, S., Singh, N., Denzongpa, P., Haldar, P., & Loharikar, A. (2021). Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018–2019. Vaccine. https://doi.org/10.1016/j.vaccine.2021.07.024
  • Ahmed, D., VanderEnde, K., Harvey, P., Bhatnagar, P., Kaur, N., Roy, S., Singh, N., Denzongpa, P., Haldar, P., & Loharikar, A. (2022). Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018–2019. Vaccine, 40(Suppl 1), A17–A25. https://doi.org/10.1016/j.vaccine.2021.07.024
  • Ali, R. F., Arif Siddiqi, D., Mirza, A., Naz, N., Abdullah, S., Kembhavi, G., Tam, C. C., Offeddu, V., & Chandir, S. (2022). Adolescent girls’ recommendations for the design of a human papillomavirus vaccination program in Sindh, Pakistan: A qualitative study. Human Vaccines & Immunotherapeutics, 18(5), 2045856. https://doi.org/10.1080/21645515.2022.2045856
  • Ammenwerth, E. (2019). Technology acceptance models in health informatics: TAM and UTAUT. Studies in Health Technology and Informatics, 263, 64–71. https://doi.org/10.3233/SHTI190111
  • Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. The Lancet Global Health, 8(2), e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6
  • Ardito, V., Golubev, G., Ciani, O., & Tarricone, R. (2023). Evaluating barriers and facilitators to the uptake of mHealth apps in cancer care using the consolidated framework for implementation research. Scoping Literature Review. JMIR Cancer, 9, e42092. https://doi.org/10.2196/42092
  • Awan, U. A., Guo, X., Khattak, A. A., Hassan, U., & Bashir, S. (2023). HPV vaccination and cervical cancer screening in Afghanistan threatened. The Lancet Infectious Diseases, 23(2), 141–142. https://doi.org/10.1016/S1473-3099(22)00868-4
  • Basu, P., & Mittal, S. (2011). Acceptability of human papillomavirus vaccine among the urban, affluent and educated parents of young girls residing in Kolkata, Eastern India. Journal of Obstetrics and Gynaecology Research, 37(5), 393–401. https://doi.org/10.1111/j.1447-0756.2010.01371.x
  • Bhuiyan, A., Sultana, F., Islam, J. Y., Chowdhury, M. A. K., & Nahar, Q. (2018). Knowledge and acceptance of human papillomavirus vaccine for cervical cancer prevention among urban professional women in Bangladesh: A mixed method study. BioResearch Open Access, 7(1), 63–72. https://doi.org/10.1089/biores.2018.0007
  • Biellik, R., Levin, C., Mugisha, E., LaMontagne, D. S., Bingham, A., Kaipilyawar, S., & Gandhi, S. (2009). Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings. Vaccine, 27(44), 6203–6209. https://doi.org/10.1016/j.vaccine.2009.08.003
  • Bingham, A., Drake, J. K., & LaMontagne, D. S. (2009). Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Archives of Pediatrics & Adolescent Medicine, 163(5), 455–461. https://doi.org/10.1001/archpediatrics.2009.50
  • Burki, T. K. (2023). India rolls out HPV vaccination. The Lancet Oncology, 24(4), e147. https://doi.org/10.1016/S1470-2045(23)00118-3
  • Burney, A., & Zafar, R. (2023). HPV vaccination as a mode of cervical cancer prevention in Pakistan. South Asian Journal of Cancer, 12(1), 51–52. https://doi.org/10.1055/s-0043-1764211
  • Canon, C., Effoe, V., Shetty, V., & Shetty, A. K. (2017). Knowledge and attitudes towards human papillomavirus (HPV) among academic and community physicians in Mangalore, India. Journal of Cancer Education, 32(2), 382–391. https://doi.org/10.1007/s13187-016-0999-0
  • Chellapandian, P., Myneni, S., Ravikumar, D., Padmanaban, P., James, K. M., Kunasekaran, V. M., Manickaraj, R. G. J., Arokiasamy, C. P., Sivagananam, P., Balu, P., Chelladurai, U. M., Veeraraghavan, V. P., Baluswamy, G., Sreekandan, R. N., Kamaraj, D., Suga, S. S. D., Kullappan, M., Ambrose, J. M., Kamineni, S. R. T., & Surapaneni, K. M. (2021). Knowledge on cervical cancer and perceived barriers to the uptake of HPV vaccination among health professionals. BMC Women’s Health. https://doi.org/10.1186/s12905-021-01205-8
  • Cutts, F. T., Franceschi, S., Goldie, S., Castellsague, X., de Sanjose, S., Garnett, G., Edmunds, W. J., Claeys, P., Goldenthal, K. L., Harper, D. M., & Markowitz, L. (2007). Human papillomavirus and HPV vaccines: A review. Bulletin of the World Health Organization, 85(9), 719–726. https://doi.org/10.2471/BLT.06.038414
  • Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009). Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implementation Science, 4(1), 50. https://doi.org/10.1186/1748-5908-4-50
  • Garland, S. M., Bhatla, N., & Ngan, H. Y. S. (2012). Cervical cancer burden and prevention strategies: Asia oceania perspective. Cancer Epidemiology, Biomarkers & Prevention, 21(9), 1414–1422. https://doi.org/10.1158/1055-9965.EPI-12-0164
  • Global Alliance for Vaccines and Immunization. (2023). Human papillomavirus vaccine support. https://www.gavi.org/types-support/vaccine-support/human-papillomavirus.
  • GLOBOCAN. (2020). Cervix uteri - International Agency for Research on Cancer. International Agent for Research on Cervic Uteri. https://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-uteri-fact-sheet.pdf.
  • Guadiana, D., Kavanagh, N. M., & Squarize, C. H. (2021). Oral health care professionals recommending and administering the HPV vaccine: Understanding the strengths and assessing the barriers. PLoS One, 16(3). https://doi.org/10.1371/journal.pone.0248047
  • Hanson, C. M., Eckert, L., Bloem, P., & Cernuschi, T. (2015). Gavi HPV programs: Application to implementation. Vaccines, 3(2), 408–419. https://doi.org/10.3390/vaccines3020408
  • Hingmire, S., Tshomo, U., Dendrup, T., Patel, A., & Parikh, P. (2023). Cervical cancer HPV vaccination and Bhutan. South Asian Journal of Cancer, 12(1), 41–43. https://doi.org/10.1055/s-0043-1764220
  • Holroyd, T. A., Yan, S. D., Srivastava, V., Srivastava, A., Wahl, B., Morgan, C., Kumar, S., Yadav, A. K., & Jennings, M. C. (2021). Designing a pro-equity HPV vaccine delivery program for girls who have dropped out of school: Community perspectives from Uttar Pradesh, India. Health Promotion Practice. https://doi.org/10.1177/15248399211046611
  • Hong, S.-A. (2023). COVID-19 vaccine communication and advocacy strategy: A social marketing campaign for increasing COVID-19 vaccine uptake in South Korea. Humanities and Social Sciences Communications, 10(1), 109. https://doi.org/10.1057/s41599-023-01593-2
  • Jacob, M., Mawar, N., Menezes, L., Kaipilyawar, S., Gandhi, S., Khan, I., Patki, M., Bingham, A., LaMontagne, D. S., Bagul, R., Katendra, T., Karandikar, N., Madge, V., Chaudhry, K., Paranjape, R., & Nayyar, A. (2010). Assessing the environment for introduction of human papillomavirus vaccine in India. The Open Vaccine Journal. https://doi.org/10.2174/1875035401003010096
  • Jindal, H. A., Kaur, A., & Murugan, S. (2017). Human papilloma virus vaccine for low and middle income countries: A step too soon? Human Vaccines & Immunotherapeutics, 13(11), 2723–2725. https://doi.org/10.1080/21645515.2017.1358837
  • Johnson, D. C., Bhatta, M. P., Gurung, S., Aryal, S., Lhaki, P., & Shrestha, S. (2014). Knowledge and awareness of human papillomavirus (HPV), cervical cancer and HPV vaccine among women in two distinct Nepali communities. Asian Pacific Journal of Cancer Prevention, 15(19), 8287–8293. https://doi.org/10.7314/APJCP.2014.15.19.8287
  • Kamath, A., Yadav, A., Baghel, J., Bansal, P., & Mundle, S. (2021). Level of awareness about HPV infection and vaccine among the medical students: A comprehensive review from India. Indian Journal of Gynecologic Oncology, 19(4). https://doi.org/10.1007/s40944-021-00553-5
  • Kaur, P., Mehrotra, R., Rengaswamy, S., Kaur, T., Hariprasad, R., Mehendale, S. M., Rajaraman, P., Rath, G. K., Bhatla, N., Krishnan, S., Nayyar, A., & Swaminathan, S. (2017). Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India. Indian Journal of Medical Research, 146(2), 153–157. https://doi.org/10.4103/ijmr.IJMR_1906_16
  • Krupp, K., Marlow, L. A. V., Kielmann, K., Doddaiah, N., Mysore, S., Reingold, A. L., & Madhivanan, P. (2010). Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India. Journal of Adolescent Health, 46(4), 379–384. https://doi.org/10.1016/j.jadohealth.2009.10.001
  • Kumari, P., & Pankaj, S. (2021). HPV vaccination programmme-hurdles & challenges in a tertiary care centre. Indian Journal of Gynecologic Oncology, 19. https://doi.org/10.1007/s40944-021-00548-2
  • Levac, D., Colquhoun, H., & O’Brien, K. K. (2010). Scoping studies: Advancing the methodology. Implementation Science, 5(1), 69. https://doi.org/10.1186/1748-5908-5-69
  • Madhivanan, P., Krupp, K., Yashodha, M. N., Marlow, L., Klausner, J. D., & Reingold, A. L. (2009). Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India. Vaccine, 27(38), 5203–5208. https://doi.org/10.1016/j.vaccine.2009.06.073
  • Madhivanan, P., Li, T., Srinivas, V., Marlow, L., Mukherjee, S., & Krupp, K. (2014). Human papillomavirus vaccine acceptability among parents of adolescent girls: Obstacles and challenges in Mysore, India. Preventive Medicine, 64, 69–74. https://doi.org/10.1016/j.ypmed.2014.04.002
  • Mahumud, R. A., Gow, J., Alam, K., Keramat, S. A., Hossain, M. G., Sultana, M., Sarker, A. R., & Islam, S. M. S. (2020). Cost-effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh. Vaccine, 38(2), 165–172. https://doi.org/10.1016/j.vaccine.2019.10.037
  • Mehta, S., Rajaram, S., Goel, G., & Goel, N. (2013). Awareness about human papilloma virus and its vaccine among medical students. Indian Journal of Community Medicine, 38(2), 92–94. https://doi.org/10.4103/0970-0218.112438
  • Meyer, G. (2015). An evidence-based healthcare system and the role of the healthcare professions. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 109(4–5), 378–383. https://doi.org/10.1016/j.zefq.2015.07.014
  • Monaco, A., Casteig Blanco, A., Cobain, M., Costa, E., Guldemond, N., Hancock, C., Onder, G., Pecorelli, S., Silva, M., Tournoy, J., Trevisan, C., Votta, M., Yfantopoulos, J., Yghemonos, S., Clay, V., Mondello Malvestiti, F., De Schaetzen, K., Sykara, G., & Donde, S. (2021). The role of collaborative, multistakeholder partnerships in reshaping the health management of patients with noncommunicable diseases during and after the COVID-19 pandemic. Aging Clinical and Experimental Research, 33(10), 2899–2907. https://doi.org/10.1007/s40520-021-01922-y
  • Mooketsane, K. S., & Phirinyane, M. B. (2015). Health governance in Sub-Saharan Africa. Global Social Policy, 15(3), 345–348. https://doi.org/10.1177/1468018115600123d
  • Núñez, I., & Valdés-Ferrer, S. I. (2023). Fulminant mpox as an AIDS-defining condition: Useful or stigmatising? Lancet (London, England), 401(10380), 881–884. https://doi.org/10.1016/S0140-6736(23)00333-1
  • Olaleye, Y. (2019). Social mobilization and community participation in development programmes (pp. 389–408). https://www.researchgate.net/profile/Yemisi-Olaleye/publication/333172944_Social_Mobilization_and_Community_Participation_in_Development_Programmes/links/5d0a395d299bf1f539cf4ebd/Social-Mobilization-and-Community-Participation-in-Development-Programmes.pd.
  • Orchowski, L. M., Oesterle, D. W., Zong, Z. Y., Bogen, K. W., Elwy, A. R., Berkowitz, A. D., & Pearlman, D. N. (2023). Implementing school-wide sexual assault prevention in middle schools: A qualitative analysis of school stakeholder perspectives. Journal of Community Psychology, 51(3), 1314–1334. https://doi.org/10.1002/jcop.22974
  • Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016). Rayyan—A web and mobile app for systematic reviews. Systematic Reviews, 5(1), 210. https://doi.org/10.1186/s13643-016-0384-4
  • Padmanabha, N., Kini, J. R., Alwani, A. A., & Sardesai, A. (2019). Acceptability of human papillomavirus vaccination among medical students in Mangalore, India. Vaccine, 37(9), 1174–1181. https://doi.org/10.1016/j.vaccine.2019.01.032
  • Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
  • Pandey, D., Vanya, V., Bhagat, S., Vs, B., & Shetty, J. (2012). Awareness and attitude towards human papillomavirus (HPV) vaccine among medical students in a premier medical school in India. PLoS One, 7(7), e40619. https://doi.org/10.1371/journal.pone.0040619
  • PATH. (2022). Global HPV vaccine introduction overview. https://media.path.org/documents/Global_Vaccine_Intro_Overview_Slides_Final_PATHwebsite_MAR_2022_qT92Wwh.pdf?_gl=1*7u8qw5*_ga*ODY4Nzk5MTkyLjE2ODE4MDQ1NzY.*_ga_YBSE7ZKDQM*MTY4MTgwNDU3NS4xLjAuMTY4MTgwNDU3NS4wLjAuMA.
  • Paul, P., Tanner, A. E., Gravitt, P. E., Vijayaraghavan, K., Shah, K. V., Zimet, G. D., & Study Group, C. (2014). Acceptability of HPV vaccine implementation among parents in India. Health Care for Women International, 35(10), 1148–1161. https://doi.org/10.1080/07399332.2012.740115
  • Peters, M. D. J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., McInerney, P., Godfrey, C. M., & Khalil, H. (2020). Updated methodological guidance for the conduct of scoping reviews. JBI Evidence Synthesis, 18(10), 2119–2126. https://doi.org/10.11124/JBIES-20-00167
  • Prinja, S., Bahuguna, P., Faujdar, D. S., Jyani, G., Srinivasan, R., Ghoshal, S., Suri, V., Singh, M. P., & Kumar, R. (2017). Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India’s universal immunization program. Cancer. https://doi.org/10.1002/cncr.30734
  • Priya, S., & Kumar, M. A. (2023). Knowledge, attitude and practice (KAP) of cervical cancer and hpv vaccine among pharmacy and paramedical female students at a private university (South India). International Journal of Pharmaceutical Research, 15. https://doi.org/10.31838/ijpr/2020.12.03.097
  • Pulerwitz, J., Michaelis, A., Weiss, E., Brown, L., & Mahendra, V. (2010). Reducing HIV-related stigma: Lessons learned from Horizons research and programs. Public Health Reports (Washington, D.C. : 1974), 125(2), 272–281. https://doi.org/10.1177/003335491012500218
  • Rajkhowa, P., Dsouza, V. S., Kharel, R., Cauvery, K., Mallya, B. R., Raksha, D. S., Mrinalini, V., Sharma, P., Pattanshetty, S., Narayanan, P., Lahariya, C., & Brand, H. (2023). Factors influencing monkeypox vaccination: A cue to policy implementation. Journal of Epidemiology and Global Health, 1–13. https://doi.org/10.1007/s44197-023-00100-9
  • Rao, B. A., Seshadri, J. G., & Thirthahalli, C. (2017). Impact of health education on HPV vaccination. Indian Journal of Gynecologic Oncology. https://doi.org/10.1007/s40944-017-0134-0
  • Rebecchi, A., Gola, M., Kulkarni, M., Lettieri, E., Paoletti, I., & Capolongo, S. (2016). Healthcare for all in emerging countries: A preliminary investigation of facilities in Kolkata, India. Annali Dell’Istituto Superiore Di Sanita, 52(1), 88–97. https://doi.org/10.4415/ANN_16_01_15
  • Reddy, N. K. K., Bahurupi, Y., Kishore, S., Singh, M., Aggarwal, P., & Jain, B. (2020). Awareness and readiness of health care workers in implementing Pradhan Mantri Jan Arogya Yojana in a tertiary care hospital at Rishikesh. Nepal Journal of Epidemiology, 10(2), 865–870. https://doi.org/10.3126/nje.v10i2.27941
  • Sankaranarayanan, R., Basu, P., Kaur, P., Bhaskar, R., Singh, G. B., Denzongpa, P., Grover, R. K., Sebastian, P., Saikia, T., Oswal, K., Kanodia, R., Dsouza, A., Mehrotra, R., Rath, G. K., Jaggi, V., Kashyap, S., Kataria, I., Hariprasad, R., Sasieni, P., … Purushotham, A. (2019). Current status of human papillomavirus vaccination in India’s cervical cancer prevention efforts. The Lancet Oncology, 20(11), e637–e644. https://doi.org/10.1016/S1470-2045(19)30531-5
  • Saxena, A. (2022). eVIN to Co-WIN: Digitizing India’s immunization programme. https://www.undp.org/india/blog/evin-co-win-digitizing-india’s-immunization-programme.
  • Shah, P., Shetty, V., Ganesh, M., & Shetty, A. K. (2021). Challenges to human papillomavirus vaccine acceptability among women in south India: An exploratory study. The American Journal of Tropical Medicine and Hygiene, 105(4), 966–973. https://doi.org/10.4269/ajtmh.20-1650
  • Shah, P. M., Ngamasana, E., Shetty, V., Ganesh, M., & Shetty, A. K. (2022). Knowledge, attitudes and HPV vaccine intention among women in India. Journal of Community Health. https://doi.org/10.1007/s10900-022-01072-w
  • Shaikh, M. Y., Hussaini, M. F., Narmeen, M., Effendi, R., Paryani, N. S., Ahmed, A., Khan, M., & Obaid, H. (2019). Knowledge, attitude, and barriers towards human papillomavirus (HPV) vaccination among youths of Karachi, Pakistan. Cureus, 11(11), e6134. https://doi.org/10.7759/cureus.6134
  • Sharma, D. C. (2013). Rights violation found in HPV vaccine studies in India. The Lancet Oncology, 14(11), e443. https://doi.org/10.1016/S1470-2045(13)70420-0
  • Shet, A., & Bar-Zeev, N. (2023). Human papillomavirus vaccination strategies for accelerating action towards cervical cancer elimination. The Lancet Global Health, 11(1), e4–e5. https://doi.org/10.1016/S2214-109X(22)00511-3
  • Shetty, S., Shetty, V., Badiger, S., & Shetty, A. K. (2021). An exploratory study of undergraduate healthcare student perspectives regarding human papillomavirus and vaccine intent in India. Women's Health, 17. https://doi.org/10.1177/17455065211055304
  • Singh, Y., Shah, A., Singh, M., Verma, S., Shrestha, B. M., Vaidya, P., Nakarmi, R. P., & Shrestha, S. B. (2010). Human papilloma virus vaccination in Nepal: An initial experience in Nepal. Asian Pacific Journal of Cancer Prevention : APJCP, 11(3), 615–617.
  • Swarnapriya, K., Kavitha, D., & Reddy, G. M. M. (2015). Knowledge, attitude and practices regarding HPV vaccination Among medical and para medical in students, India a cross sectional study. Asian Pacific Journal of Cancer Prevention, 16(18), 8473–8477. https://doi.org/10.7314/APJCP.2015.16.18.8473
  • Thammatacharee, N., Tisayaticom, K., Suphanchaimat, R., Limwattananon, S., Putthasri, W., Netsaengtip, R., & Tangcharoensathien, V. (2012). Prevalence and profiles of unmet healthcare need in Thailand. BMC Public Health, 12(1), 923. https://doi.org/10.1186/1471-2458-12-923
  • The Economic Times. (2021). The Indian cold chain sector is expected to grow at 14% CAGR during 2021–2023. https://economictimes.indiatimes.com/industry/services/property-/-cstruction/the-indian-cold-chain-sector-is-expected-to-grow-at-14-cagr-during-2021-2023/articleshow/83426568.cms.
  • The World Bank. (2016). Bangladesh: Ensuring education for all Bangladeshis. https://www.worldbank.org/en/results/2016/10/07/ensuring-education-for-all-bangladeshis.
  • The World Bank. (2023a). Low & middle income. https://data.worldbank.org/income-level/low-and-middle-income.
  • The World Bank. (2023b). South Asia. https://data.worldbank.org/country/8S.
  • Tran, B. X., Than, P. Q. T., Tran, T. T., Nguyen, C. T., & Latkin, C. A. (2019). Changing sources of stigma against patients with HIV/AIDS in the rapid expansion of antiretroviral treatment services in Vietnam. BioMed Research International, 4208638. https://doi.org/10.1155/2019/4208638
  • Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., Garritty, C., … Straus, S. E. (2018). PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Annals of Internal Medicine, 169, 467–473. https://doi.org/10.7326/M18-0850
  • Tsui, J., LaMontagne, D. S., Levin, C., Bingham, A., & Menezes, L. (2009). Policy development for human papillomavirus vaccine introduction in low-resource settings. The Open Vaccine Journal. https://doi.org/10.2174/1875035400902010113
  • UNICEF. (2021). Building confidence in the COVID-19 vaccine in India. https://www.unicef.org/india/stories/building-confidence-covid-19-vaccine-india.
  • Van Boekholt, T. A., Duits, A. J., & Busari, J. O. (2019). Health care transformation in a resource-limited environment: Exploring the determinants of a good climate for change. Journal of Multidisciplinary Healthcare, 12, 173–182. https://doi.org/10.2147/JMDH.S194180
  • Wigle, J., Coast, E., & Watson-Jones, D. (2013). Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects. Vaccine, 31(37), 3811–3817. https://doi.org/10.1016/j.vaccine.2013.06.016
  • World Health Organisation. (2020). Global strategy to accelerate the elimination of cervical cancer as a public health problem. https://www.who.int/publications/i/item/9789240014107.
  • World Health Organization. (2014). Principles and considerations for adding a vaccine to a national immunization programme: from decision to implementation and monitoring. https://apps.who.int/iris/handle/10665/111548?search-result=true&query=HPV+vaccine&current-scope=10665%2F26724&rpp=10&sort_by=score&order=desc&page=3.
  • World Health Organization. (2016a). Guide to introducing HPV vaccine into national immunization programmes. https://apps.who.int/iris/bitstream/handle/10665/253123/9789241549769-eng.pdf?sequence=1&isAllowed=y.
  • World Health Organization. (2016b). HPV vaccine introduced in Bangladesh. https://www.who.int/bangladesh/news/detail/18-05-2016-hpv-vaccine-introduced-in-bangladesh.
  • World Health Organization. (2016c). National immunization programme: HPV vaccine demonstration programme in Kaski and Chitwan. https://un.info.np/Net/NeoDocs/View/7108.
  • World Health Organization. (2020). Global strategy to accelerate the elimination of cervical cancer as a public health problem. https://www.who.int/publications/i/item/9789240014107.
  • World Health Organization. (2022a). Human papillomavirus (HPV) vaccination coverage. https://immunizationdata.who.int/pages/coverage/hpv.html.
  • World Health Organization. (2022b). Risk communication and community engagement (RCCE) for monkeypox outbreaks: Interim guidance, 24 June 2022. https://www.who.int/publications/i/item/WHO-MPX-RCCE-2022.1.
  • World Health Organization. (2022c). Universal health coverage (UHC). health coverage %28UHC%29 means that all people,rehabilitation%2C and palliative care across the life course.